What can Biologics Modelling do for you?
Protein-based drugs are one of the most important classes of therapeutics. Despite this, the field of rational design of biologics remains challenging. Recently, in silico technologies have emerged as valuable tools in both discovery and development.
In this webinar, we will discuss how a range of computational solutions can be used to overcome typical problems in the field including structure prediction, epitope mapping, protein engineering and developability.
In this webinar we will discuss:
About Schrödinger:
Schrodinger is a provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The company is also applying its computational platform to a robust pipeline of drug discovery programs in collaboration with pharmaceutical companies and has co-founded leading biotech companies.
In addition, the company is using its platform to advance a pipeline of internal, wholly-owned drug discovery programs.
More information at www.schrodinger.com
In this webinar, we will discuss how a range of computational solutions can be used to overcome typical problems in the field including structure prediction, epitope mapping, protein engineering and developability.
In this webinar we will discuss:
- Protein structure prediction
- Protein docking/epitope mapping
- In silico mutagenesis
- Protein developability
About Schrödinger:
Schrodinger is a provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The company is also applying its computational platform to a robust pipeline of drug discovery programs in collaboration with pharmaceutical companies and has co-founded leading biotech companies.
In addition, the company is using its platform to advance a pipeline of internal, wholly-owned drug discovery programs.
More information at www.schrodinger.com